NASDAQ: DXCMDexcom Inc Stock Ownership - Who owns Dexcom?
Insider buying vs selling
Have Dexcom Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Jon Brown | EVP Chief Legal Officer | 2025-08-15 | 500 | $80.29 | $40.15kSell |
| Mark G. Foletta | Director | 2025-08-15 | 2,555 | $81.02 | $207.00kSell |
| Mark G. Foletta | Director | 2025-08-15 | 195 | $81.54 | $15.90kSell |
| Sadie Stern | EVP Chief HR Officer | 2025-07-28 | 1,466 | $88.99 | $130.46kSell |
| Mark G. Foletta | Director | 2025-07-15 | 8 | $86.03 | $688.24Sell |
| Michael Jon Brown | EVP Chief Legal Officer | 2025-07-15 | 500 | $86.03 | $43.02kSell |
| Mark G. Foletta | Director | 2025-07-15 | 2,742 | $85.17 | $233.53kSell |
| Sadie Stern | EVP Chief HR Officer | 2025-06-26 | 1,466 | $85.06 | $124.70kSell |
| Nicholas Augustinos | Director | 2025-06-16 | 3,672 | $82.80 | $304.04kSell |
| Mark G. Foletta | Director | 2025-06-16 | 2,750 | $83.13 | $228.60kSell |
DXCM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when DXCM insiders and whales buy or sell their stock.
DXCM Shareholders
What type of owners hold Dexcom Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 12.32% | 48,322,405 | $3.64B | Institution |
| Blackrock Inc | 9.95% | 39,032,096 | $2.94B | Institution |
| State Street Corp | 4.30% | 16,858,078 | $1.27B | Institution |
| Baillie Gifford Co | 4.26% | 16,705,195 | $1.26B | Institution |
| Jennison Associates LLC | 2.94% | 11,517,546 | $867.73M | Institution |
| Geode Capital Management LLC | 2.75% | 10,766,356 | $811.14M | Institution |
| Sands Capital Management LLC | 2.54% | 9,947,944 | $749.48M | Institution |
| Ubs Am A Distinct Business Unit Of Ubs Asset Management Americas LLC | 2.33% | 9,130,614 | $687.90M | Institution |
| Nuveen LLC | 1.93% | 7,568,890 | $570.24M | Institution |
| Massachusetts Financial Services Co | 1.68% | 6,605,687 | $497.67M | Institution |
DXCM vs Medical Device Stocks
Dexcom Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.